Robert Bider, a Swiss national, holds a PhD in Sciences and a Master in Industrial Management (MIM) from the Federal Institute of Technology, Zurich (ETHZ). Mr. Bider started his career in 1972 as Head of the Organization Department of the University Hospital, Zurich. In 1977, he became Head of the Consulting Department of the Swiss Hospital Institute. From 1985 to 2008, he was Chief Executive Officer of Hirslanden, where he devised and executed the expansion scheme of Hirslanden from a single hospital to the largest Swiss private hospital group with 1300 beds, over 100 centres of competence, 5'000 employees and a turnover of CHF 1.1 billion. He is Chairman of the Hirslanden Research Foundation, the Robert Bider Foundation, member of the Foundation for the Lucerne Symphony Orchestra and President of the Swiss Corporate Tennis Association. Mr. Bider is also Chairman of European Medical Network EMN AG and member of the non-executive Board of Median Kliniken. Further, he is on the board of Pioneer Medical Devices AG, Lumendi Ltd., Embru AG and Montana Capital Partners AG. He was Chairman of the Board of SENIOcare AG, the largest Swiss chain of nursing homes, from 2009 until it was sold to Swiss Prime Site in 2015. He was also a board member of Grand Resort Bad Ragaz, Medi-Clinic Switzerland AG, Medi-Clinic Corporation Ltd. and Rhino-Partners AG.
Patrick Schildknecht, a Swiss national, holds a master of business administration at the University of Zurich. He started his career with the door manufacturer Portico S.A. in San Jose, Costa Rica. After returning to Switzerland in 1999, he worked five years as a strategy consultant with Arthur D. Little in Singapore and Switzerland. In 2004 he served as owner and CEO of Sycrilor Industries S.A. in Le Noirmont, a precision forge for the luxury goods and medical industry. Mr. Schildknecht is the owner and president of SK Holding AG in Euthal, an investment company with several subsidiaries in retail trading as well as in the property development and building materials sectors. Patrick Schildknecht has acted as a member of the Board of Directors in several public and private companies.
Antoine Hubert, a Swiss national, serves as Vice Chairman of the Board of Directors. Mr. Hubert is a founder and Delegate of the Board of AEVIS Holding SA as well as one of the two main shareholders of the firm. AEVIS Holding SA invests in the healthcare sector, life sciences and personal care services. AEVIS's main shareholdings are Genolier Swiss Medical Network, the second largest group of private clinics in Switzerland, and Swiss Healthcare Properties AG, a company specialized in medical real estate, Nescens SA, a brand dedicated to better aging, and AS Ambulances Services SA. AEVIS Holding SA is listed on the Domestic Standard segment of the SIX Swiss Exchange under AEVIS. Prior to acquiring a stake in Clinique de Genolier in 2002 and founding Genolier Swiss Medical Network in 2004, Antoine Hubert was mainly active in the property and real estate industry and has set up various businesses and served as a director to several companies in different industries.
Thomas Rühle, a German national, holds a degree in economics from the BA Karlsruhe. He served as Vice President Europe of Sanofi Pasteur MSD from 2005 till 2011. Previously, he acted as Chairman for the region Germany at Sanofi Pasteur MSD. Prior to Sanofi Pasteur MSD he held several marketing positions at leading pharmaceutical companies. Today he is involved in several healthcare and logistics companies as a private investor.
Raymond W. Cohen, a citizen of the United States of America, is an accredited public company director and medical device veteran with over 30 years of operating and board level experience. Mr. Cohen currently serves as the CEO and a board member of Axonics Modulation Technologies, Inc. Irvine, CA, USA. Mr. Cohen is a member of several boards of Directors; he is Chairman of the Board of Lombard Medical Inc. Didcot, UK, Chairman of the Board of BioLife Solutions Inc., Bothell, WA, a Board member of Spectrum Pharmaceuticals Inc., Henderson, NV, a Board member of JenaValve Technology, Irvine, CA, and Chairman of the Board, Syncroness, Inc., Westminster, CO.
Antoine Kohler is a Swiss national, and holds a law degree from the University of Geneva. Following postgraduate studies at the Graduate Institute of International Studies, Geneva, Antoine Kohler has been practicing law as a qualified attorney in Geneva since 1983. He is a senior partner of the law firm Perréard de Boccard SA, with offices in Geneva and Zurich. Antoine Kohler is member of several boards of Directors; he is amongst others a board member of AEVIS VICTORIA SA, Fribourg and certain AEVIS group companies, Chairman of the Board of Airopack Technology Group AG, Baar, Deputy Chairman of Mitsubishi UFJ Wealth Management Bank (Switzerland) Ltd., Geneva, and a board member of Sixt Leasing (Schweiz AG), Urdorf, and Sixt rent-a-car AG, Basel. Up until 2015 Antoine Kohler was also Chairman of Cicor Technologies Ltd, Boudry.
Jinsheng Dong, a Chinese citizen, holds an EMBA of China Europe International Business School (CEIBS) 2014 and a bachelor in economics of Bejing Technology and Business University 1996. He began his career with China Oil and Foodstuffs Import and Export from 1996 – 1999, following which he held leading positions in the marketing area of China Hewlett-Packard. From 2000 – 2014 he served as Sales Manager, Sales Director and Support Sales General Manager of China Hewlett-Packard. In 2014 he joined the management board of Zhuhai Hokai Medical Instruments Co., Ltd, where he is responsible for the division of mobile health products. He is also a Board member and third largest shareholder of Beijing Hospmail Technology Co., Ltd., a subsidiary of Zhuhai Hokai Medical Instruments.